![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 21, 17800-17807, May 25, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute of Signalisation, Developmental Biology
and Cancer, INSERM 470, Centre de Biochimie, Université de Nice,
Faculté des Sciences, 06108 Nice, France
Depriving primary bone marrow-derived macrophages
of colony-stimulating factor-1 (CSF-1) induces programmed cell death by apoptosis. We show that cell death is accompanied by decreases in the
expression of anti-apoptotic Bcl-xL protein and the
Ets2 and PU.1 proteins of the Ets transcription factor family.
Macrophages require both priming and triggering signals independent of
CSF-1 to kill neoplastic cells or microorganisms, and this activation of macrophage competence is accompanied by increased expression of
bcl-xL, ets2, and
PU.1. Furthermore, we show that only Ets2 and PU.1,
but not Ets1, function in a synergistic manner to transactivate the
bcl-x promoter. The synergy observed between PU.1 and Ets2
is dependent on the transactivation domains of both proteins. Although
other transcription factors like Fos, c-Jun, Myc, STAT3, and STAT5a are
implicated in the activation of macrophage competence or in CSF-1
signaling, no synergy was observed between Ets2 and these transcription
factors on the bcl-x promoter. We demonstrate that the
exogenous expression of both Ets2 and PU.1 in macrophages increases the
number of viable cells upon CSF-1 depletion and that Ets2 and PU.1 can
functionally replace Bcl-xL in inhibiting Bax-induced
apoptosis. Together, these results demonstrate that PU.1 and Ets2
dramatically increase bcl-x activation, which is necessary
for the cytocidal function and survival of macrophages.
Bcl-xL Expression Correlates with Primary Macrophage
Differentiation, Activation of Functional Competence, and Survival
and Results from Synergistic Transcriptional Activation by Ets2 and
PU.1*
,
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by European Communities Grant ERBFMBICT972684
and by the Foundation pour la Recherche Medicale.
§
Supported by Ministère de L'Education Nationale de La
Recherche et de la Technologie.
¶
Supported by Association pour la Recherche contre le Cancer
Grant 9691. To whom correspondence should be addressed. Tel. and Fax:
33-4-92-07-64-13; E-mail: boulukos@unice.fr.
This article has been cited by other articles:
![]() |
K. M. Irvine, C. J. Burns, A. F. Wilks, S. Su, D. A. Hume, and M. J. Sweet A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations FASEB J, September 1, 2006; 20(11): 1921 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yao, P. Li, Q. Zhang, E. M. Schwarz, P. Keng, A. Arbini, B. F. Boyce, and L. Xing Tumor Necrosis Factor-{alpha} Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression J. Biol. Chem., April 28, 2006; 281(17): 11846 - 11855. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Flaherty, M. M. Monick, and S. L. Hinde Human Alveolar Macrophages Are Deficient in PTEN: THE ROLE OF ENDOGENOUS OXIDANTS J. Biol. Chem., February 24, 2006; 281(8): 5058 - 5064. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Himes, D. P. Sester, T. Ravasi, S. L. Cronau, T. Sasmono, and D. A. Hume The JNK Are Important for Development and Survival of Macrophages J. Immunol., February 15, 2006; 176(4): 2219 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Firlej, B. Bocquet, X. Desbiens, Y. de Launoit, and A. Chotteau-Lelievre Pea3 Transcription Factor Cooperates with USF-1 in Regulation of the Murine bax Transcription without Binding to an Ets-binding Site J. Biol. Chem., January 14, 2005; 280(2): 887 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Galang, W. J. Muller, G. Foos, R. G. Oshima, and C. A. Hauser Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors J. Biol. Chem., March 19, 2004; 279(12): 11281 - 11292. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Blouin, E. L. Page, G. M. Soucy, and D. E. Richard Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1{alpha} Blood, February 1, 2004; 103(3): 1124 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Man, L. J. T. Young, J. A. Tynan, J. Lesperance, M. Egeblad, Z. Werb, C. A. Hauser, W. J. Muller, R. D. Cardiff, and R. G. Oshima Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors Mol. Cell. Biol., December 1, 2003; 23(23): 8614 - 8625. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Cheng and S. Handwerger Identification of an Enhancer of the Human Activating Protein-2{alpha} Gene That Contains a Critical Ets1 Binding Site J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3305 - 3311. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hashmueli, M. Gleit-Kielmanowicz, D. Meraro, A. Azriel, D. Melamed, and B.-Z. Levi A truncated IFN-regulatory factor-8\IFN consensus sequence-binding protein acts as dominant-negative, interferes with endogenous protein-protein interactions and leads to apoptosis of immune cells Int. Immunol., July 1, 2003; 15(7): 807 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zaldumbide, F. Carlotti, P. Pognonec, and K. E. Boulukos The Role of the Ets2 Transcription Factor in the Proliferation, Maturation, and Survival of Mouse Thymocytes J. Immunol., November 1, 2002; 169(9): 4873 - 4881. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |